Feltl & Co Upgrades ResMed (RMD) to Strong Buy
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $224.46 --0%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Join SI Premium – FREE
Feltl & Co upgraded ResMed (NYSE: RMD) from Buy to Strong Buy, price target lowered from $39.10 to $35.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $24.33 yesterday.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $24.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- Investec Double Upgrades Alkem Laboratories Ltd (ALKEM:IN) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
